Early research shows it may produce even greater weight loss and fat reduction than semaglutide
The TriNetX platform has been used in retrospective cohort studies [25,26,27,28,29,30,31,32,33,34,35,36,37,38] including evaluating risk and health outcomes of patients with substance use disorders including CUD [25, 32, 35] and the associations of GLP-1RAs with cancer [37] and semaglutide with suicidal ideations [38]
On the other hand, changes in the vaginal microbiome or vaginal pH during weight loss could make it easier for yeast to overgrow if protective bacteria are disrupted, according to Dr
Wegovy works through several pathways that directly benefit liver health: Weight loss reduces liver fat
Tirzepatides dual hormone approach allows for greater reductions in appetite and improved fat utilization
Patients who took weekly doses of tirzepatide reduced their risk of developing type 2 diabetes by 94%, compared to patients who were on a placebo